Scott Thomas Jackson

Director at Spero Therapeutics · 3 reported transactions in 2 companies · latest report Jun 23, 2026

Their trades


Spero TherapeuticsSPRO	Share award — · 10,000 shares	Jun 23, 2026
MacrogenicsMGNX	Exercised options — · 3,750 shares	May 18, 2026
Spero TherapeuticsSPRO	Share award — · 20,000 shares	Jun 12, 2025

Share awardSpero Therapeutics

Jun 23, 2026 · SPRO

10,000

Exercised optionsMacrogenics

May 18, 2026 · MGNX

3,750

Share awardSpero Therapeutics

Jun 12, 2025 · SPRO

20,000

3 transactionsPro adds every trade with how it did, their holdings and the money-flow chartPro is $29 a month

Built from their public trade reports and market prices: past moves, not predictions or advice.